NEO
NEO
NASDAQ · Health Care

Neogenomics Inc

$8.46
+0.09 (+1.08%)
Financial Highlights (FY 2026)
Revenue
750.08M
Net Income
-111,406,725
Gross Margin
43.2%
Profit Margin
-14.9%
Rev Growth
+12.6%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 750.08M 666.27M 759.46M 804.45M
Gross Profit 324.11M 287.89M 380.80M 403.36M
Operating Income -119,488,243 -95,522,667 67.00M 69.80M
Net Income -111,406,725 -89,062,046 56.53M 50.19M
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Rev Growth +12.6% +12.6% -7.8% -8.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 157.88M 157.88M 99.64M 90.17M
Total Equity 386.40M 386.40M 945.36M 961.54M
D/E Ratio 0.41 0.41 0.11 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -82,356,163 -69,495,785 95.37M 98.54M
Free Cash Flow 21.30M 34.74M